Urdaci et al., 2004 - Google Patents
Bacillus clausii probiotic strains: antimicrobial and immunomodulatory activitiesUrdaci et al., 2004
View PDF- Document ID
- 8945699373423428610
- Author
- Urdaci M
- Bressollier P
- Pinchuk I
- Publication year
- Publication venue
- Journal of clinical gastroenterology
External Links
Snippet
The clinical benefits observed with probiotic use are mainly attributed to the antimicrobial substances produced by probiotic strains and to their immunomodulatory effects. Currently, the best-documented probiotic bacteria used in human therapy are lactic acid bacteria. In …
- 230000000529 probiotic 0 title abstract description 74
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Urdaci et al. | Bacillus clausii probiotic strains: antimicrobial and immunomodulatory activities | |
| Khushboo et al. | Characterization and selection of probiotic lactic acid bacteria from different dietary sources for development of functional foods | |
| Spinosa et al. | On the fate of ingested Bacillus spores | |
| Angelakis et al. | Related actions of probiotics and antibiotics on gut microbiota and weight modification | |
| Jose et al. | Implications of antibiotic resistance in probiotics | |
| Hart et al. | Use of probiotics in the treatment of inflammatory bowel disease | |
| Thomas et al. | Probiotics-host communication: modulation of signaling pathways in the intestine | |
| Hong et al. | The use of bacterial spore formers as probiotics | |
| Moroni et al. | Inactivation of adhesion and invasion of food-borne Listeria monocytogenes by bacteriocin-producing Bifidobacterium strains of human origin | |
| Coconnier et al. | Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB | |
| Macfarlane et al. | Probiotics, infection and immunity | |
| Sanders | Probiotics: considerations for human health | |
| Szachta et al. | An evaluation of the ability of the probiotic strain Lactobacillus rhamnosus GG to eliminate the gastrointestinal carrier state of vancomycin-resistant enterococci in colonized children | |
| Carasi et al. | Safety characterization and antimicrobial properties of kefir‐isolated Lactobacillus kefiri | |
| Meurman et al. | Probiotics: contributions to oral health | |
| Song et al. | What roles do probiotics play in the eradication of Helicobacter pylori? Current knowledge and ongoing research | |
| Poppi et al. | Effect of Lactobacillus sp. isolates supernatant on Escherichia coli O157: H7 enhances the role of organic acids production as a factor for pathogen control | |
| Del Piano et al. | Evaluation of the intestinal colonization by microencapsulated probiotic bacteria in comparison with the same uncoated strains | |
| Romyasamit et al. | Optimization of cryoprotectants for freeze-dried potential probiotic Enterococcus faecalis and evaluation of its storage stability | |
| Tsai et al. | Immunomodulating activity of Lactobacillus paracasei subsp. paracasei NTU 101 in enterohemorrhagic Escherichia coli O157H7-infected mice | |
| Lu et al. | Bacillus-derived probiotics: metabolites and mechanisms involved in bacteria–host interactions | |
| Mulaw et al. | Protective effect of potential probiotic strains from fermented ethiopian food against Salmonella Typhimurium DT104 in mice | |
| Bhunia | Bacillus cereus and Bacillus anthracis | |
| Mathipa et al. | Cocktails of probiotics pre-adapted to multiple stress factors are more robust under simulated gastrointestinal conditions than their parental counterparts and exhibit enhanced antagonistic capabilities against Escherichia coli and Staphylococcus aureus | |
| Dini et al. | Treatment of in vitro enterohemorrhagic Escherichia coli infection using phage and probiotics |